Transcat, Inc.

TRNS ·Technology, Scientific & Technical Instruments, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Dec 2025 Sep 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $92.9M $83.9M $82.3M $82.3M $76.4M $77.1M $66.8M $67.8M
Cost of Revenue $62.2M $58.6M — $55.5M $50.6M $51.2M $47.1M $46.6M
Gross Profit $30.7M $25.3M — $26.8M $25.8M $25.9M $19.7M $21.2M
Gross Margin 33.1% 30.1% — 32.5% 33.8% 33.6% 29.5% 31.3%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $15.6M $13.8M — $12.6M $11.0M $9.7M $9.5M $9.3M
Operating Income $3.7M $88.0K — $3.5M $5.3M $6.9M $2.1M $3.7M
Operating Margin 4.0% 0.1% — 4.3% 7.0% 9.0% 3.1% 5.5%
Interest Expense — — — — — — — —
Pretax Income $2.2M $-1.4M — $2.0M $4.6M $6.3M $3.1M $3.7M
Income Tax Expense $854.0K $-338.0K — $760.0K $1.3M $1.8M $772.0K $427.0K
Net Income $1.3M $-1.1M — $1.3M $3.3M $4.5M $2.4M $3.3M
Net Margin 1.4% -1.3% — 1.5% 4.3% 5.8% 3.5% 4.8%
EPS (Basic) $0.14 $-0.12 — $0.14 $0.35 $0.47 $0.26 $0.36
EPS (Diluted) $0.14 $-0.12 — $0.14 $0.35 $0.49 $0.25 $0.35
Shares Outstanding (Basic) 9.4M 9.3M — 9.3M 9.3M 9.2M 9.2M 9.2M
Shares Outstanding (Diluted) 9.5M 9.3M — 9.4M 9.4M 9.3M 9.3M 9.3M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 9 Older →